Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of acetylcysteine on renal function after radiographic contrast exposure
2006-003509-18Phase 4Completed
- Sponsor
- University of Edinburgh
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of acetylcysteine in contrast-associated acute kidney injury (CA-AKI), sponsored by University of Edinburgh. Primary endpoint: Change in renal blood flow. Started Jun 2007; status: completed.
02
Drugs
acetylcysteine
03
Conditions
contrast-associated acute kidney injury (CA-AKI)
Beyond the preview
Go deeper on 2006-003509-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003509-18.